Latham BioPharm Group Article Wins BPI Readers’ Choice Award!

“Each year BioProcess International publishes over 150 technical and scientific articles focusing on the latest science, technologies, and techniques supporting biopharmaceutical research, development, and manufacturing.” BioProcess International, Your Choices for BPI’s Best Articles, 2021

This year’s rankings were constructed based on views, engagement, and download rates; and led to the selection of the four most popular articles within each of BPI’s six pillars of bioprocessing coverage.

Winning 2nd Place in the Cell & Gene Therapies category – the article titled, “Capacity Analysis for Viral Vector Manufacturing: Is There Enough?” was co-authored by Latham BioPharm Group team members: Joseph Rininger, Ashley Fennell, Lauren Schoukroun-Barnes, Christopher Peterson, and Joshua Speidel. The article was honored as one of the most read and appreciated papers in the cell and gene therapies category.

Set up a meeting with Dr. Rininger or one of our other Latham BioPharm Group team members today to learn more about our cell and gene therapies capabilities!